Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05730010 · ClinicalTrials.gov registry record
Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 289
- Enrollment target
NCT05730010 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 289 participants.
The verdict
NCT05730010 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 289 participants
- Enrollment target
Study Summary
This study will examine how ctDNA and additional prognostic genomic information in patients with early stage breast cancer might influences patient decision- making regarding systemic therapy options.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 289 participants |
| Start Date | 2023-04-16 |
| Est. Completion | 2023-06-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05730010
The ClinicalTrials.gov registry entry for NCT05730010 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 289 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05730010 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05730010 about?
NCT05730010 is a clinical study titled "Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis". This study will examine how ctDNA and additional prognostic genomic information in patients with early stage breast cancer might influences patient decision- making regarding systemic therapy options.
What is the current status of trial NCT05730010?
This trial is currently completed. The enrollment target is 289 participants. The study started on 2023-04-16. Estimated completion is 2023-06-26.
Who is sponsoring clinical trial NCT05730010?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.